Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients. - Wikidata - wikimedia - TriplyDB

Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients.

Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients.

http://www.wikidata.org/entity/Q46758127

about

Hepatitis C virus protease inhibitor-resistance mutations: our experience and review Platelet count and sustained virological response in hepatitis C treatment.Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response.Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV Natural interferon-beta treatment for patients with chronic hepatitis C in Japan Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin.IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based test Comparison of Three Different Methods for Detection of IL28 rs12979860 Polymorphisms as a Predictor of Treatment Outcome in Patients with Hepatitis C Virus.Alanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatment IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase.Treatment of hepatitis C virus infection in the future.Novel biosensor-based microarray assay for detecting rs8099917 and rs12979860 genotypes.A comparative study of various methods for detection of IL28B rs12979860 in chronic hepatitis C.Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1.Natural interferon-beta plus ribavirin therapy led to sustained virological response after seven unsuccessful courses of anti-viral treatment in a chronic hepatitis C patient.IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.Allele-specific PCR for determination of IL28B genotype Occurrence of hepatocellular carcinoma was not a rare event during and immediately after antiviral treatment in Japanese HCV-positive patients.Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy.

P2860

Q24628717-493EC0ED-0111-498B-9FDA-ADAC85C133CE Q33407719-142F6A4A-79B0-4BB9-A082-A444E002964D Q33423299-49F7ECDD-3B59-47A3-BC48-99B835B23F61 Q34007851-E394F3FC-8096-4FA8-A3BD-AB7EA048E9A6 Q34103218-8C1CA810-B64B-445E-8CA6-2DFB60761F81 Q35069533-019414E7-29C2-47F5-A531-CACA7C6748CF Q35668734-AF2DF920-F819-4EEC-9B6F-F30498868D0D Q35947900-88BFD0ED-3BEA-4649-A36E-ADBD154E5F1C Q36246785-949FCCE5-F383-4731-9027-9871AFCFF5B3 Q36836988-8D78F745-96A6-4579-AF99-6F85F41CD20F Q36850395-DE62760C-2207-450C-AB6F-CFE8C2A0BF49 Q36953126-BFA7F837-2171-4F5C-9B13-34CFE3753E65 Q37358287-BEE64046-A455-4372-B65F-ECDB1E39F83E Q39436509-98B570A2-A70B-466B-AC69-D3D11137A88B Q40077714-2012E5C8-AEEB-43B9-A508-C4ADF7B47F48 Q40298456-A285A7E2-0264-44F6-9A3E-26BAEE2F14B3 Q40707649-1493EEBB-89D6-4939-80B4-C1956330D329 Q40729480-8954D117-F702-4DDF-8840-631781888306 Q41576433-E4698C53-D354-41E7-8780-C43CE476D53B Q41637827-FD85FC00-9905-404E-8FE7-FCB4267B9337 Q43039523-A27C2191-CDEA-43A9-B9C4-D678BA82DBD7 Q47112537-782C51D5-7F0A-4F5D-BD3A-E704DDF8F9F5

P2860

Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients.

http://www.wikidata.org/entity/Q46758127

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Simple assay based on restrict ...... chronic hepatitis C patients.

@en

Simple assay based on restrict ...... chronic hepatitis C patients.

@nl

type

label

Simple assay based on restrict ...... chronic hepatitis C patients.

@en

Simple assay based on restrict ...... chronic hepatitis C patients.

@nl

prefLabel

Simple assay based on restrict ...... chronic hepatitis C patients.

@en

Simple assay based on restrict ...... chronic hepatitis C patients.

@nl

P1433

Q46758127-3631ED0C-ECA8-45F8-A946-1A2C859E8D8C

P1476

Q46758127-CC9CE5B6-5DCB-4650-BC21-0F8237BFAB5D

P2093

Q46758127-33EFB7B8-7B33-44A3-834A-14E825C6C0E8

Q46758127-347EF454-7357-4128-B863-CE91A6ADC3D3

Q46758127-8AED7625-F643-4B6B-9DF8-F3E9DDF331BA

Q46758127-9D0D8569-954D-4288-B21F-5F086E856FFC

Q46758127-D2931960-B9BE-4A92-9685-37BD4C518561

Q46758127-E98BDC6D-7133-48D1-BE81-4C9807ED4210

Q46758127-F2CB0AD6-76D2-4A95-8ABD-7F74C1FD83A3

P2860

Q46758127-06850895-D028-4772-AC80-AB226EC13C42

Q46758127-22A18CF3-0B3E-4EEB-B9A2-B0D0C8766770

Q46758127-24670564-DE91-4601-A405-313920A382CA

Q46758127-2B9FE8FE-037D-48C6-A348-65C0159454B7

Q46758127-6070B15E-37C5-43AA-B8A1-EBF72E23F5A4

Q46758127-7B020BBA-89EB-40C5-89E6-29562D684EE8

Q46758127-87CBA30D-A662-4CCC-A214-E6DEF6D1C63E

Q46758127-9E93D765-08B7-483C-8E1F-4BDF86654480

Q46758127-9F119D64-DA14-4A51-AE82-1A108278820B

Q46758127-A57444D7-735F-4015-A12D-B56C326BDAEF

P304

Q46758127-E0983229-A60C-4CF8-BA12-330B21A303CD

P31

Q46758127-E8BD580E-4B1F-47E4-A05E-0CE8EEAD3CFD

P356

Q46758127-52AEC1A0-0F5B-4C3F-A5F1-8DBAA6B82219

P433

Q46758127-43B8804F-693B-421B-9C11-09717CDC516B

P478

Q46758127-CA2B38AD-1549-4503-8DCB-44590641CFAF

P577

Q46758127-526758B5-6EB2-4A0F-B9B8-34EB654CE2B7

P698

Q46758127-92FC339B-309B-4D11-9959-98E72B2820B6

P356

00365521.2011.574731

P1433

Scandinavian Journal of Gastroenterology

P1476

Simple assay based on restrict ...... chronic hepatitis C patients.

@en

P2093

Fumio Imazeki

http://www.w3.org/2001/XMLSchema#string

Keiichi Fujiwara

http://www.w3.org/2001/XMLSchema#string

Makoto Arai

http://www.w3.org/2001/XMLSchema#string

Osamu Yokosuka

http://www.w3.org/2001/XMLSchema#string

Shingo Nakamoto

http://www.w3.org/2001/XMLSchema#string

Shuang Wu

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kanda

http://www.w3.org/2001/XMLSchema#string

P2860

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Diagnosis, management, and treatment of hepatitis C: an update

New antiviral therapies for chronic hepatitis C

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

Fine-scaled human genetic structure revealed by SNP microarrays

Peginterferon and ribavirin for chronic hepatitis C.

P304

955-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365521.2011.574731

http://www.w3.org/2001/XMLSchema#string

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21529139

http://www.w3.org/2001/XMLSchema#string